2899 |
Enhancing CV Outcomes: Treat CV Risk Factors Not Just Cholesterol |
Jong-Young Lee |
Apr. 21. 16 |
2898 |
Growing Importance of Evidence in the Management of High CV Risk Patients |
Duk-Woo Park |
Apr. 21. 16 |
2897 |
Benefit of Adding Ezetimibe to Statin Therapy in ACS Patients |
Sang Yup Lim |
Apr. 21. 16 |
2896 |
Taped Case: PPVI (1) - Medtronic Melody Valve |
Jae Young Choi |
Apr. 21. 16 |
2895 |
Percutaneous Pulmonary Valve Replacement: State of the Art |
Damien Kenny |
Apr. 21. 16 |
2894 |
Efficacy of Ultimaster in CTO PCI¡¡ |
Yuji Hamazaki |
Apr. 21. 16 |
2893 |
Bifucation Case Review of Ultimaster |
Ho Kay Woon |
Apr. 21. 16 |
2892 |
Where Are We with PFO Closure? Long-Term Outcome from Randomized Trials |
Damien Kenny |
Apr. 21. 16 |
2891 |
Calcified Lesion - Debulking Followed by Bioresorablable Ploymer Stenting |
Tarun Dave |
Apr. 21. 16 |
2890 |
Initial Experience with a Bioresorbable ASD/PFO Occluder |
Horst Sievert |
Apr. 21. 16 |